Sepp-Lorenzino Laura

Sepp-Lorenzino Laura is listed in filings as Director at Taysha Gene Therapies, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Taysha Gene Therapies, Inc. (TSHA), Lexeo Therapeutics, Inc. Common Stock (LXEO), and Intellia Therapeutics, Inc. (NTLA). The current snapshot covers public activity from Jan 3, 2025 to Jun 2, 2026. Reported amounts are shown as $254.7K to $315.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.